Discover the leading code analysis tools for DevOps teams in 2025. Enhance your software development process with automated security and quality checks to mitigate risks and improve code health.

This important study combines optogenetic manipulations and wide-field imaging to show that the retrosplenial cortex controls behavioral responses to whisker deflection in a context-dependent manner.

This study presents SynaptoGen, a differentiable extension of connectome models that links gene expression, protein-protein interaction probabilities, synaptic multiplicity, and synaptic weights, and ...

Introduction This article outlines the research protocol for a multicentre, randomised, controlled study designed to evaluate the therapeutic effect of a modified olfactory training (MOT) based on ...

'Magical footage has surfaced from Bodmin Moor, UK, which shows countless lovely starlings beautifying the sky via their coordinated flight. "Saw a starling murmuration beside Rough Tor on Bodmin Moor ...

Using a new computer model, scientists simulated the stripes, spots and hexagons on a species of boxfish, imperfections and all. A male ornate boxfish with distinctive, complex patterns of stripes and ...

A mixture of two types of pigment-producing cells undergoes diffusiophoretic transport to self-assemble into a hexagonal pattern. Credit: Siamak Mirfendereski and Ankur Gupta/CU Boulder A zebra’s ...

Scroll down for a transcription of this episode. What happens when imagination meets perception, and ordinary objects come alive? We explore the science of pareidolia. Summary: Our minds are wired to ...

This paper presents the most comprehensive and up-to-date panel dataset on global trade invoicing currency and examines recent pattern shifts with a focus on geopolitical alignment. Using data for 132 ...

Bloom patterns could be useful, as engineers build folding structures to send to outer space. They’re also very pretty. Researchers have now found a new class of origami that they call bloom patterns, ...

In an Aug. 7 earnings call, Eli Lilly CEO David Ricks told investors that the company plans to submit the drug, orforglipron, to the FDA for approval by the end of the year. Dan Skovronsky, chief ...